Recent Progress in Carrier‐Free Nanomedicine for Tumor Phototherapy-Reference-Cited by-同舟云学术

Recent Progress in Carrier‐Free Nanomedicine for Tumor Phototherapy

Published:2022-11-24 Issue:4 Volume:12 Page:2202307
ISSN:2192-2640
Container-title:Advanced Healthcare Materials
language:en
Short-container-title:Adv Healthcare Materials

Author:

Zhong Ying‐Tao¹,Cen Yi²,Xu Lin³,Li Shi‐Ying²,Cheng Hong¹^ORCID

Affiliation:

1. Biomaterials Research Center School of Biomedical Engineering & Guangdong Provincial Key Laboratory of Construction and Detection in Tissue Engineering Southern Medical University Guangzhou 510515 P. R. China

2. School of Pharmaceutical Sciences Guangzhou Medical University Guangzhou 511436 P. R. China

3. Department of Geriatric Cardiology General Hospital of the Southern Theatre Command People's Liberation Army (PLA) and Guangdong Pharmaceutical University Guangzhou 510016 P. R. China

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adhm.202202307

Reference248 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Analysis of status and countermeasures of cancer incidence and mortality in China

3. Surgical stress and cancer progression: the twisted tango

4. Novel nanomedicines to overcome cancer multidrug resistance

5. Radiotherapy toxicity

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor microenvironment-sensitive polymeric nanoparticles for synergetic chemo-photo therapy;Chinese Chemical Letters;2024-11

2. Recent advances and clinical challenges of phototherapeutic nanoparticles in cancer monotherapy or combination therapy;Coordination Chemistry Reviews;2024-11

3. Research progress in tumor therapy of carrier-free nanodrug;Biomedicine & Pharmacotherapy;2024-09

4. Recent developments in two-dimensional molybdenum disulfide-based multimodal cancer theranostics;Journal of Nanobiotechnology;2024-08-28

5. Engineered Carrier-Free Nanosystem-Induced In Situ Therapeutic Vaccines for Potent Cancer Immunotherapy;ACS Applied Materials & Interfaces;2024-08-27